| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-05 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |